| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fab5a78161702097f97524ce6e5cdcd7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2b77c65806db108d1c8e7762bd3bf92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e2ff282264aabbc8ce3217c31e935c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca58ca36d0299125d531bc42b1041a11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71c77b5239ca31e9b2075c99511a717f |
| publicationDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018229210-A1 |
| titleOfInvention |
Use of the extracellular domain of transferrin receptor 2 for the diagnosis and treatment of primary or secondary sclerosing diseases |
| abstract |
The invention relates to a protein for use in the diagnosis and treatment of primary or secondary sclerosing diseases, a fusion protein, a nucleotide sequence, a vector and a pharmaceutical composition for use in the diagnosis and treatment of primary and secondary sclerosing diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019238713-A3 |
| priorityDate |
2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |